New: NCI-funded clinical trial search
Mednet Logo

What do you view as reasonable alternatives to cyclophosphamide in the treatment of neuropsychiatric lupus?

Community PollStarted

Have you had experience with sirolimus in SLE?

5 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · UTMB Health
Answered on

In general, I very seldom, if ever, rely on cyclophosphamide anymore to treat lupus in general, and much less neuropsychiatric lupus, with few exceptions. As above mentioned, we start off with corticosteroids, followed by a second-line agent, which can be azathioprine, CellCept, Rituxan, etc. We hav...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Mobile Medical Care Inc
Answered on

“A reasonable alternative” to cyclophosphamide in NPSLE is an amazing statement that belies the reality of this state. We have to recognize that NPSLE includes underlying pathophysiology that includes inflammation of meninges, cerebral tissue, and/or vasculature that may or may not be separate from ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · SUNY Upstate Medical University
Answered on

There is peer-reviewed evidence that sirolimus blocks seizures in patients with tuberous sclerosis. We do have the experience that sirolimus helps all forms of SLE, including neuropsychiatric lupus. Our experience is consistent with the overwhelming evidence that mTOR activation is found in patients...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · PSN
Answered on

CNS lupus is perhaps one of the most challenging diagnoses, especially for a community rheumatologist. Due to toxicity of cyclophosphamide, it is scary to start it unless I am convinced that it is a true vasculitis rather than multi factorial process including thrombosis/psychiatric manifestations. ...

Join for free or sign in to see the full answer